EGFR and non-small cell lung carcinoma: On the other hand, other clinical demographics were consistent with previous research: elderly onset, a relatively high proportion of pleomorphic carcinoma and squamous cell carcinoma compared to the proportion in EGFR-mutated or ALK-rearranged NSCLC, and no significant differences in sex or smoking history [13, 15–19].